OX40/TNFRSF4 Protein, Mouse, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 22.1 kDa and the accession number is B1ASL3.
生物活性 | Testing in progress |
产品描述 | OX40/TNFRSF4 Protein, Mouse, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 22.1 kDa and the accession number is B1ASL3. |
种属 | Mouse |
表达系统 | HEK293 Cells |
标签 | Tag Free |
蛋白编号 | B1ASL3 |
别名 | ACT35, CD134, Ox40, tumor necrosis factor receptor superfamily, member 4, Ly-70, TXGP1L, Txgp1 |
蛋白构建 | The Mouse Tnfrsf4 (NP_035789.1) (Met1-Pro211) was expressed with six amino acids (LEVLFQ) at the C-terminus. |
蛋白纯度 | > 95 % as determined by SDS-PAGE. |
分子量 | 22.1 kDa (predicted) |
内毒素 | < 1.0 EU/μg of the protein as determined by the LAL method. |
缓冲液 | Lyophilized from a solution filtered through a 0.22 μm filter, containing PBS, pH 7.4. Typically, a mixture containing 5% to 8% trehalose, mannitol, and 0.01% Tween 80 is incorporated as a protective agent before lyophilization. |
复溶方法 | A Certificate of Analysis (CoA) containing reconstitution instructions is included with the products. Please refer to the CoA for detailed information. |
存储 |
It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at-80℃. For reconstituted proteinsolutions, the solution can be stored at -20°c to -80'c for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
运输方式 |
In general, Lyophilized powders are shipping with blue ice. |
研究背景 | OX40 (CD134) and its binding partner, OX40L (CD252), are members of the tumor necrosis factor receptor/tumor necrosis factor superfamily, is known to break an existing state of tolerance in malignancies, leading to a reactivation of antitumor immunity. The interaction between OX40 and OX40L plays an important role in antigen-specific T-cell expansion and survival. OX40 and OX40L also regulate cytokine production from T cells, antigen-presenting cells, natural killer cells, and natural killer T cells, and modulate cytokine receptor signaling. In line with these important modulatory functions, OX40-OX40L interactions have been found to play a central role in the development of multiple inflammatory and autoimmune diseases, making them attractive candidates for intervention in the clinic. Conversely, stimulating OX40 has shown it to be a candidate for therapeutic immunization strategies for cancer and infectious disease.Cancer ImmunotherapyCo-stimulatory Immune Checkpoint TargetsImmune CheckpointImmune Checkpoint Detection: AntibodiesImmune Checkpoint Detection: ELISA AntibodiesImmune Checkpoint Detection: WB AntibodiesImmune Checkpoint ProteinsImmune Checkpoint TargetsImmunotherapyTargeted Therapy |
bottom
您可能有的问题的答案可以在重组蛋白操作手册中找到
OX40/TNFRSF4 Protein, Mouse, Recombinant ACT-35 ACT35 CD-134 CD134 CD 134 Ox40 ACT 35 tumor necrosis factor receptor superfamily, member 4 Ly-70 TXGP1L Txgp1 recombinant recombinant-proteins proteins protein